The Type II Diabetes drug, Actos has received a black box label, has had a label change warning of a 40% increase in the risk for bladder cancer, and has been banned in France and Germany. Yet, Actos still remains on the market in the United States. Ringler Radio, host Larry Cohen joins colleague Martin C. Blount and Attorney Michael J. Miller, from The Miller Firm LLC, to discuss the side effects of the diabetes medication Actos, including its connection to bladder cancer, reaction of the FDA, and recent litigation.
Visit Ringler Associates to contact a consultant in your area about structured settlements.
Medical devices and pharmaceutical drugs undergo rigorous testing and must receive pre‑market approval from the FDA before they are available to the public. Unfortunately, all too often, defects and severe side effects that may or may not have been latent during testing and trials create hazardous products. On Ringler Radio, host Larry Cohen welcomes colleague and co-host Ann Marie VonBank and guest, Attorney James T. Capretz, to discuss the current litigation against the makers of some of the most dangerous drugs and medical devices.
An estimated 10 million Americans are taking Darvocet, Darvon and other medications today for their pain. Darvon and Darvocet were removed from the US market after a safety study showed heart risk. On Ringler Radio, host Larry Cohen welcomes Attorney Frank Woodson, from the Montgomery, Alabama firm of Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., to take a look at the effects of Darvon and Darvocet, the FDA’s role and the litigation that will follow. Larry and Frank discuss how the FDA has changed under the new Obama administration, what to do if you are experiencing side effects from these drugs and if we will see an increase in lawsuits involving Darvon/Darvocet in 2011.
Bayer HealthCare Pharmaceuticals is facing a growing number of lawsuits claiming that the company concealed the health risks associated with the top-selling birth control pills Yaz and Yasmin. Co-hosts and attorneys J. Craig Williams and Bob Ambrogi welcome Attorney Mike Danko from the Danko Law Firm and James T. O’Reilly, Professor of Law at University of Cincinnati College of Law, to a look at the basis for the litigation, the reported side affects, the FDA’s role, Bayer’s continued marketing campaign and the federal lawsuit against the makers of Yaz & Yasmin.
Recently, Zicam products have come under fire after people who used the popular over the counter nasal spray were losing their sense of smell. Ringler Radio host Larry Cohen welcomes Attorney Fred Thompson III from Motley Rice to take a look at the effects of Zicam, the FDA’s warning, consumer protection issues and Zicam litigation.
How will the pharmaceutical companies, doctors and patients and legal cases be impacted by the recent SUPCO ruling in the Wyeth v. Levine case? Join Law.com bloggers and co-hosts, J. Craig Williams and Bob Ambrogi as they welcome Wyeth’s attorney, Bert W. Rein, founding partner of the law firm, Wiley Rein LLP, to discuss the wide-reaching impact this ruling will have for many years to come.
You may have heard about the Gardasil vaccine, but you may not have heard about the serious side effects, allegedly affecting some young women. Merck, the company that manufactures the vaccine, the CDC and the FDA all say Gardasil is safe, effective, and important. Join Law.com bloggers and co-hosts, J. Craig Williams and Bob Ambrogi, who will discuss this controversy and the litigation swirling around Gardasil with experts, Attorney Tom Girardi, nationally known plaintiff lawyer from the California firm, Girardi & Keese and Erin Brockovich, (yes the real Erin Brockovich from the movie by the same name), President of Brockovich Research & Consulting. They will take a look at the side effects in some cases, Gardasil litigation and focus in on the efforts to educate young women about this controversial vaccine.